U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Monday.
Shares of argenx SE – ADR (NASDAQ:ARGX) fell sharply in pre-market trading after the company discontinued its Phase 3 UplighTED studies of efgartigimod SC in thyroid eye disease following a futility review.
argenx shares dipped 6% to $825.00 in pre-market trading.
Here are some other stocks moving lower in pre-market trading.
- TryHard Holdings Ltd (NASDAQ:THH) shares tumbled 15.2% to $13.16 in pre-market trading after jumping 58% on Friday.
- Site Centers Corp (NYSE:SITC) declined 13.4% to $6.33 in pre-market trading.
- Exicure Inc (NASDAQ:XCUR) dipped 8.7% to $5.80 in pre-market trading after gaining 5% on Friday.
- Celldex Therapeutics Inc (NASDAQ:CLDX) declined 8.4% to $25.19 in pre-market trading.
- CapsoVision Inc (NASDAQ:CV) fell 6.4% to $12.03 in pre-market trading after declining around 11% on Friday.
- Zillow Group Inc (NASDAQ:Z) fell 5.6% to $70.50 in pre-market trading.
- BeOne Medicines AG (NASDAQ:ONC) declined 4.9% to $303.50 in pre-market trading.
- ServiceNow Inc (NYSE:NOW) fell 4.7% to $824.50 in pre-market trading after KeyBanc downgraded the stock to Underweight.
- WaterBridge Infrastructure LLC (NYSE:WBI) fell 4.4% to $20.05 in pre-market trading.
- Pharming Group N V (NASDAQ:PHAR) declined 4.2% to $17.23 in pre-market trading.
Photo via Shutterstock
Recent Comments